Jason Coogan, Simplex Trading, joins 'Squawk on the Street' to discuss the relationship between oil and stocks, how traders ...
AllAfrica on MSN
PAC Chairperson Malondera Accuses Acting ACB Director Chembezi of Threats, Influence Peddling in Amaryllis Probe
The Chairperson of Parliament's Public Accounts Committee (PAC), Steven Baba Malondera Kamsiyamo, MP, has lodged a formal complaint accusing the Acting Director General of the Anti-Corruption Bureau ...
BLANTYRE-(MaraviPost)-The recent arrests of several former Malawi Congress Party ministers and senior officials have ...
Lucra offers corporate loyalty programs reimagined as interactive eSports. But winning ARK as a lead wasn't easy.
Opinion
FDA Issues CRL to Replimune for RP1 Biologics License Application for Advanced Melanoma Treatment
Replimune received a second FDA complete response letter for RP1 in advanced melanoma, raising questions about the viability of its oncolytic immunotherapy program. Replimune Group received a complete ...
Replimune has had its advanced melanoma treatment RP1 turned down by the FDA for a second time, a decision that has led the company to accuse the agency of inconsistencies in its review of the drug.
Replimune disagrees with the FDA about whether the data set, upon which breakthrough therapy designation was awarded, is sufficient to allow this promising medicine to be made available to advanced ...
Far more than a superficial epithelial problem, corneal melt is a progressive ulceration of corneal stromal tissue that can compromise the structural integrity of the eye. Corneal melt often precedes ...
In a collective exhibition titled 'Shared Matter', Swiss designers are presenting global collaborations at this year's Milan ...
What started as a late-40s idea that most biotech experts would have called impossible is now a $7.9 billion company. Built ...
Geographers quibble over whether the Amazon or the Nile is the longest river in the world. It depends on where the river’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results